Heron Historical Income Statement

HRTX Stock

USD 1.63 0.06 3.82%

Historical analysis of Heron Therapeuti income statement accounts such as Total Revenue of 153.4 M or Gross Profit of 74.8 M can show how well Heron Therapeuti performed in making a profits. Evaluating Heron Therapeuti income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Heron Therapeuti's future profits or losses.

Cash Flow Balance Sheet Income Statement

Oil Shock

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Heron Therapeuti latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Heron Therapeuti is a good buy for the upcoming year.

Net Income Gross Profit

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Heron Therapeuti. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Heron Stock please use our How to Invest in Heron Therapeuti guide.

About Heron Income Statement Analysis

Heron Therapeuti Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Heron Therapeuti shareholders. The income statement also shows Heron investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Heron Therapeuti Income Statement Chart

At this time, Heron Therapeuti's Depreciation And Amortization is fairly stable compared to the past year. Interest Expense is likely to rise to about 4.7 M in 2025, despite the fact that Operating Income is likely to grow to (94.6 M).

Cost Of Revenue Total Operating Expenses Research Development Discontinued Operations

Cost Of Revenue

Cost of Revenue is found on Heron Therapeuti income statement and represents the costs associated with goods and services Heron Therapeuti provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Most accounts from Heron Therapeuti's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Heron Therapeuti current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Heron Therapeuti. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Heron Stock please use our How to Invest in Heron Therapeuti guide.At this time, Heron Therapeuti's Depreciation And Amortization is fairly stable compared to the past year. Interest Expense is likely to rise to about 4.7 M in 2025, despite the fact that Operating Income is likely to grow to (94.6 M).

	2022	2023	2024	2025 (projected)
Total Operating Expenses	227.5M	172.6M	198.4M	208.4M
Cost Of Revenue	54.9M	65.1M	74.9M	78.6M

Total Operating Expenses Cost Of Revenue

Heron Therapeuti income statement Correlations

	Depreciation And Amortization	Interest Expense	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Research Development	Selling General Administrative	Discontinued Operations	Net Income From Continuing Ops	Selling And Marketing Expenses	Non Operating Income Net Other	Net Interest Income	Interest Income	Reconciled Depreciation
Depreciation And Amortization		0.77	0.91	0.81	0.86	-0.56	-0.55	-0.54	0.69	0.78	-0.56	-0.07	-0.53	-0.22	0.46	0.9	0.45	-0.61	0.87	0.11	0.42	0.09	0.92
Interest Expense	0.77		0.7	0.66	0.7	-0.46	-0.44	-0.43	0.49	0.64	-0.46	-0.01	-0.46	0.05	0.34	0.78	0.57	-0.51	0.71	0.07	0.19	0.01	0.61
Total Revenue	0.91	0.7		0.9	0.86	-0.48	-0.47	-0.46	0.75	0.76	-0.47	0.21	-0.45	-0.12	0.44	0.86	0.44	-0.52	0.87	0.34	0.67	0.42	0.81
Gross Profit	0.81	0.66	0.9		0.81	-0.51	-0.5	-0.49	0.4	0.74	-0.5	0.28	-0.48	-0.08	0.49	0.64	0.24	-0.54	0.86	0.42	0.67	0.43	0.69
Other Operating Expenses	0.86	0.7	0.86	0.81		-0.86	-0.85	-0.84	0.58	0.98	-0.85	0.17	-0.84	-0.14	0.81	0.8	0.59	-0.88	0.97	0.52	0.69	0.38	0.69
Operating Income	-0.56	-0.46	-0.48	-0.51	-0.86		1.0	1.0	-0.24	-0.93	1.0	-0.11	0.99	0.15	-0.97	-0.49	-0.55	1.0	-0.8	-0.59	-0.55	-0.26	-0.38
Ebit	-0.55	-0.44	-0.47	-0.5	-0.85	1.0		1.0	-0.23	-0.93	1.0	-0.1	0.99	0.16	-0.98	-0.48	-0.55	1.0	-0.8	-0.59	-0.55	-0.26	-0.36
Ebitda	-0.54	-0.43	-0.46	-0.49	-0.84	1.0	1.0		-0.22	-0.93	1.0	-0.11	0.99	0.16	-0.98	-0.47	-0.54	1.0	-0.79	-0.59	-0.55	-0.26	-0.35
Cost Of Revenue	0.69	0.49	0.75	0.4	0.58	-0.24	-0.23	-0.22		0.47	-0.24	0.01	-0.22	-0.13	0.18	0.85	0.54	-0.27	0.53	0.08	0.39	0.24	0.68
Total Operating Expenses	0.78	0.64	0.76	0.74	0.98	-0.93	-0.93	-0.93	0.47		-0.93	0.19	-0.92	-0.13	0.9	0.72	0.6	-0.95	0.94	0.58	0.68	0.36	0.58
Income Before Tax	-0.56	-0.46	-0.47	-0.5	-0.85	1.0	1.0	1.0	-0.24	-0.93		-0.07	0.99	0.18	-0.97	-0.49	-0.56	1.0	-0.8	-0.56	-0.53	-0.22	-0.38
Total Other Income Expense Net	-0.07	-0.01	0.21	0.28	0.17	-0.11	-0.1	-0.11	0.01	0.19	-0.07		-0.17	0.73	0.25	0.04	-0.04	-0.07	0.09	0.76	0.67	0.82	-0.23
Net Income	-0.53	-0.46	-0.45	-0.48	-0.84	0.99	0.99	0.99	-0.22	-0.92	0.99	-0.17		0.03	-0.97	-0.48	-0.55	0.99	-0.77	-0.59	-0.54	-0.26	-0.34
Income Tax Expense	-0.22	0.05	-0.12	-0.08	-0.14	0.15	0.16	0.16	-0.13	-0.13	0.18	0.73	0.03		-0.09	-0.05	-0.05	0.17	-0.22	0.23	0.08	0.28	-0.3
Research Development	0.46	0.34	0.44	0.49	0.81	-0.97	-0.98	-0.98	0.18	0.9	-0.97	0.25	-0.97	-0.09		0.4	0.48	-0.96	0.74	0.71	0.65	0.39	0.27
Selling General Administrative	0.9	0.78	0.86	0.64	0.8	-0.49	-0.48	-0.47	0.85	0.72	-0.49	0.04	-0.48	-0.05	0.4		0.64	-0.54	0.76	0.15	0.42	0.19	0.81
Discontinued Operations	0.45	0.57	0.44	0.24	0.59	-0.55	-0.55	-0.54	0.54	0.6	-0.56	-0.04	-0.55	-0.05	0.48	0.64		-0.57	0.5	0.21	0.26	0.12	0.36
Net Income From Continuing Ops	-0.61	-0.51	-0.52	-0.54	-0.88	1.0	1.0	1.0	-0.27	-0.95	1.0	-0.07	0.99	0.17	-0.96	-0.54	-0.57		-0.83	-0.55	-0.53	-0.23	-0.42
Selling And Marketing Expenses	0.87	0.71	0.87	0.86	0.97	-0.8	-0.8	-0.79	0.53	0.94	-0.8	0.09	-0.77	-0.22	0.74	0.76	0.5	-0.83		0.45	0.62	0.31	0.73
Non Operating Income Net Other	0.11	0.07	0.34	0.42	0.52	-0.59	-0.59	-0.59	0.08	0.58	-0.56	0.76	-0.59	0.23	0.71	0.15	0.21	-0.55	0.45		0.88	0.86	-0.11
Net Interest Income	0.42	0.19	0.67	0.67	0.69	-0.55	-0.55	-0.55	0.39	0.68	-0.53	0.67	-0.54	0.08	0.65	0.42	0.26	-0.53	0.62	0.88		0.91	0.27
Interest Income	0.09	0.01	0.42	0.43	0.38	-0.26	-0.26	-0.26	0.24	0.36	-0.22	0.82	-0.26	0.28	0.39	0.19	0.12	-0.23	0.31	0.86	0.91		-0.03
Reconciled Depreciation	0.92	0.61	0.81	0.69	0.69	-0.38	-0.36	-0.35	0.68	0.58	-0.38	-0.23	-0.34	-0.3	0.27	0.81	0.36	-0.42	0.73	-0.11	0.27	-0.03

Click cells to compare fundamentals

Heron Therapeuti Account Relationship Matchups

Heron Therapeuti income statement Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Depreciation And Amortization	2.8M	3.0M	2.9M	2.9M	3.3M	3.5M
Interest Expense	1.9M	2.4M	2.5M	3.9M	4.4M	4.7M
Total Revenue	88.6M	86.3M	107.7M	127.0M	146.1M	153.4M
Gross Profit	52.4M	40.3M	52.8M	61.9M	71.2M	74.8M
Other Operating Expenses	316.8M	304.2M	282.3M	237.7M	273.3M	287.0M
Operating Income	(228.2M)	(217.8M)	(174.7M)	(110.6M)	(99.6M)	(94.6M)
Ebit	(228.2M)	(217.8M)	(174.7M)	(106.7M)	(96.0M)	(91.2M)
Ebitda	(225.3M)	(214.8M)	(171.8M)	(103.8M)	(93.4M)	(88.7M)
Cost Of Revenue	36.2M	46.0M	54.9M	65.1M	74.9M	78.6M
Total Operating Expenses	280.6M	258.2M	227.5M	172.6M	198.4M	208.4M
Income Before Tax	(227.3M)	(220.7M)	(182.0M)	(110.6M)	(99.5M)	(94.5M)
Total Other Income Expense Net	885K	(2.9M)	(7.4M)	56K	50.4K	47.9K
Net Income	(224.4M)	(217.7M)	(134.5M)	(110.6M)	(99.5M)	(94.5M)
Income Tax Expense	(2.8M)	(3.0M)	(47.5M)	2.7M	2.5M	2.6M
Research Development	174.5M	130.8M	107.5M	55.9M	64.3M	48.9M
Selling General Administrative	42.2M	40.2M	37.4M	49.0M	56.4M	59.2M
Net Income Applicable To Common Shares	(204.7M)	(227.3M)	(220.7M)	(182.0M)	(163.8M)	(172.0M)
Net Income From Continuing Ops	(227.3M)	(220.7M)	(182.0M)	(119.7M)	(107.7M)	(113.1M)
Selling And Marketing Expenses	63.9M	87.2M	82.5M	67.6M	77.8M	64.4M
Non Operating Income Net Other	7.8M	7.4M	2.8M	(445K)	(511.8K)	(486.2K)
Net Interest Income	1.7M	(2.0M)	(836K)	(504K)	(579.6K)	(550.6K)
Interest Income	3.6M	433K	1.6M	3.4M	3.0M	2.6M
Reconciled Depreciation	2.8M	3.0M	2.9M	3.0M	3.4M	2.6M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

BTC	Bitcoin
TRX	TRON
BNB	Binance Coin

Additional Tools for Heron Stock Analysis

When running Heron Therapeuti's price analysis, check to measure Heron Therapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heron Therapeuti is operating at the current time. Most of Heron Therapeuti's value examination focuses on studying past and present price action to predict the probability of Heron Therapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heron Therapeuti's price. Additionally, you may evaluate how the addition of Heron Therapeuti to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Heron Historical Income Statement

About Heron Income Statement Analysis

Heron Therapeuti Income Statement Chart

Cost Of Revenue

Total Operating Expenses

Heron Therapeuti income statement Correlations

Heron Therapeuti Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Heron Therapeuti income statement Accounts

Also Currently Popular

Additional Tools for Heron Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Ebit	+ 1.0	Operating Income
Ebitda	+ 1.0	Operating Income
Income Before Tax	+ 1.0	Operating Income
Net Income From Continuing Ops	+ 1.0	Operating Income
Ebitda	+ 1.0	Ebit
Income Before Tax	+ 1.0	Ebit

Research Development	- 0.98	Ebitda
Research Development	- 0.98	Ebit
Research Development	- 0.97	Net Income
Research Development	- 0.97	Income Before Tax
Research Development	- 0.97	Operating Income
Net Income From Continuing Ops	- 0.96	Research Development